期刊文献+

544例精神障碍住院患者抗抑郁药超说明书用药调查 被引量:3

Investigation on the off-label use of antidepressants in 544 inpatients with mental disorders
下载PDF
导出
摘要 目的调查我院精神障碍住院患者中抗抑郁药的超说明书用药情况,为制订合理的超说明书用药策略提供基础数据。方法采用回顾性调查研究方法,分层抽样法筛选出2017年1月1日至2017年12月31日我院使用抗抑郁药的出院精神疾病患者544例,应用自编住院患者用药信息调查表,以CFDA药品说明书作为判定依据,从适应症、给药剂量、给药人群3个方面进行超说明书用药判定。结果我院精神障碍住院患者中抗抑郁药的超说明书用药率为44.3%,超适应症用药率32.2%、超剂量用药率12.7%、超人群用药率2.4%;精神分裂症、神经症性疾病(躯体化障碍、应激相关障碍、分离(转换)性障碍)、非器质性失眠症、器质性精神障碍、精神活性物质所致精神障碍的超适应症用药率为100.0%,焦虑障碍的超适应症用药率也较高(84.4%);抗抑郁药的超人群使用体现在儿童青少年和老年人群中。结论我院抗抑郁药超说明书用药现象较普遍,以超适应症用药最多见,提示应加强医院用药规范管理及探讨超说明书用药的合理性。 Objective To investigate the off-label use of antidepressants in 544 inpatients with mental disorders of our hospital,and provide the basic data for formulating the rational strategy of off-label use.Methods With a retrospective study,a total of 544 discharged psychiatric patients from January 1,2017 to December 31,2017 who used antidepressants were selected by stratified sampling method.We used the self-designed questionnaire to investigate the medication information of these inpatients,and judged the off-label use of antidepressants from three aspects:indications,dosage and population,according to the CFDA drug directions.Results The total usage rate of the off-label prescribing of antidepressants was 44.3%.The usage rate of over-indication was 32.2%.The usage rate of over-dosage was 12.7%and the usage rate of over-population was 2.4%.The usage rate of over-indication was 100.0%in schizophrenia,neurotic disorders(somatoform disorders,stress-related disorders,dissociative(conversion)disorders),non-organic insomnia,organic disorders and mental disorders caused by psychoactive substances.The usage rate of over-indication in anxiety disorder was 84.4%.The over-population use of antidepressants was reflected in children,adolescents and the elderly.Conclusion Off-label use of antidepressants was a common phenomenon in our hospital,and the over-indication use was the most.It suggests us to strengthen the standardized management of drug use and discuss the rationality of off-label use.
作者 董雪冰 高滢 武孟丽 张明 苏中华 DONG Xuebing;GAO Ying;WU Mengli;ZHANG Ming;SU Zhonghua(School of Mental Health,Jining Medical University,Jining 272013,China;The Second Affiliated Hospital of Jining Medical University,Jining 272051,China)
出处 《济宁医学院学报》 2019年第3期206-209,共4页 Journal of Jining Medical University
关键词 抗抑郁药 超说明书用药 精神障碍 住院患者 Antidepressants Off-label use Mental disorders Inpatients
  • 相关文献

参考文献8

二级参考文献136

  • 1广东省药学会.药品未注册用法专家共识.2010年3月18日.
  • 2玛西娅·安吉尔.制药业的真相[M].北京:北京师范大学出版社,2006:88-102.
  • 3American Society of Hospital Pharmacists. ASHP statement on the use of medications for unlabeled uses. Am Hospital Pharm, 1992, 49(8): 2006-2008.
  • 4Herring C, McManus A, Weeks A. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liver- pool Women's Hospital. The International ournal Of Pharmacy Practice, 2010, 18(4): 226-229.
  • 5Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BM, 2000, 320(7227): 79-82.
  • 6Hames A. Unlicensed and off-label drug use in elderly people. Age And Ageing, 2001, 30(6): 530-531.
  • 7Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypi- cal antipsychotic drugs in patients with Alzheimer's Disease. N Engl Med, 2006, 355(15): 1525-1538.
  • 8Huntzinger A. FDA warns against off-label use of antipsychotic drugs. Am Faro Physician, 2005, 71(61): 2205.
  • 9Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med, 2006, 166(9): 1021-1026.
  • 10Miller L. Rules set for dissemination of off-label-use information. Am Health-Syst Pharm, 1999, 56(3): 204-206.

共引文献259

同被引文献26

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部